Skip to main content
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
52.59
-0.21 (-0.40%)
Mar 7, 2025, 4:00 PM EST - Market closed

PTC Therapeutics Revenue by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Net Product
600.95M 601.31M 609.92M 651.30M 661.25M 633.70M 623.84M 592.95M
Net Product Growth
-9.12% -5.11% -2.23% 9.84% 23.55% 20.33% 22.79% 26.85%
Royalty
203.86M 196.70M 185.51M 169.18M 168.86M 157.73M 140.48M 125.46M
Royalty Growth
20.73% 24.71% 32.05% 34.85% 48.74% 66.14% 86.96% 87.58%
Collaboration
304.00K - - - 100.03M - - 50.05M
Collaboration Growth
-99.70% - - - 99.85% - - 42.81%
Manufacturing
- - 5.00M 7.06M 7.69M 6.72M 4.35M 1.99M
Manufacturing Growth
- - 14.85% 255.08% - - - -

Revenue by Product
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Translarna
340.30M 321.50M 318.20M 344.30M 355.80M 336.40M 344.00M 324.50M
Translarna Growth
-4.36% -4.43% -7.50% 6.10% 23.28% 11.21% 17.37% 20.77%
Emflaza
206.70M 224.10M 239.60M 258.00M 255.10M 245.80M 233.20M 224.30M
Emflaza Growth
-18.97% -8.83% 2.74% 15.02% 16.86% 18.34% 16.60% 16.64%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.